Most Popular

The Emerging Dominance of Microsoft in the AI Arena

—

April 7, 2024

InvestorPlace – Stock Market News, Stock Advice & Trading Tips While Microsoft (NASDAQ:MSFT) has not been setting investors’ hearts ablaze of late, a closer ...

The Reddit Rollercoaster: A Wild Ride or a Steady Climb Ahead?

By Ron Finklestien

—

April 7, 2024

Reddit (NYSE: RDDT) entered the public arena with fireworks, debuting at $34 per share, soaring to $74.90, then settling back around $46. After this ...

Top Growth Stocks to Watch During a Stock Market Downturn

By Ron Finklestien

—

April 6, 2024

Stock market volatility is inevitable, and growth stocks are especially susceptible to drastic fluctuations. Typically among the first to rebound during an upturn, these ...

The Impact of Bird Flu on Corn Demand: A Closer Look at Market Dynamics

By Ron Finklestien

—

April 6, 2024

Market Fluctuations: A Rollercoaster Ride If you had told me after last week’s strong post-USDA performance that corn would have erased all those gains ...

Exploring the Viability of Investing in Meta Platforms for Dividends The Meta Platforms Dividend Dilemma

By Ron Finklestien

—

April 6, 2024

Unpacking Meta Platforms’ Business Fortunes Investors seeking dividend income must analyze a company’s foundations, weighing its ability to withstand economic storms. Can Meta Platforms, ...

The Renaissance of Dividend Investing Through the Eyes of Daniel Peris

By Ron Finklestien

—

April 6, 2024

Step into the realm of investor speculation, where historical context merges with financial foresight. Daniel Peris, a distinguished historian turned portfolio manager and author, ...

Embracing the Return of Dividend Investing: A Paradigm Shift in the Making

By Ron Finklestien

—

April 6, 2024

Renowned portfolio manager and historian, Daniel Peris, sheds light on the resurgence of dividend investing in a compelling discussion with Deidre Woollard from The ...

The Saga of Aldeyra Therapeutics (ALDX) Stock Rally: A Triumph of Strategic Clinical Endeavors

By Ron Finklestien

—

April 6, 2024

Fortunes Turn for Aldeyra Aldeyra Therapeutics’ ALDX meteoric 43.3% stock rally in just a week has left investors both jubilant and intrigued. The company’s ...

The Future of Apple: An Insightful Look at R&D Spending The Future of Apple: An Insightful Look at R&D Spending

By Ron Finklestien

—

April 6, 2024

The arrival of Apple’s Vision Pro, a highly anticipated “spatial computing” device, has not quite been the catalyst investors were hoping for. Instead, Apple ...